Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of GZR18 in Chinese Patients with T2DM
NCT06256523Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bofanglutide in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Jun 2022; status: completed.
02
Drugs
bofanglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06256523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06256523.